In accordance with our findings, Zhou et al. [28] indicated the expression of LPCAT1 in metastatic prostate cancer was higher than primary prostate cancer, and the LPCAT1 level was correlated to the tumour grade and stage. Here, LPCAT1 is linked to metastatic prostate carcinoma.